Ouch?
All six cases in the United States occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination, according to a statement issued by the Food and Drug Administration and the Centers for Disease Control and Prevention. One vaccine recipient died and another is in critical condition, an FDA official said Tuesday….
…
Despite a recent dip in shipments of Johnson & Johnson’s vaccine, clinics were scheduled for use of the shot throughout the country, from a Walmart drive-through in Bentonville, Ark., to a clinic at Canisius College in Buffalo. The one-shot option has proved popular for many people who have gravitated to its convenience, and states have deployed it in a variety of settings, from mass sites to targeted efforts to reach transient populations, such as the homeless.
Sites in a handful of states temporarily halted use of Johnson & Johnson’s vaccine last week after adverse reactions were reported, though these were immediate events consistent with common side effects of some vaccines, such as dizziness. The adverse reactions were reported in Colorado, Georgia, Iowa and North Carolina. CDC said it investigated and found no reason for concern.
The White House said Tuesday that the pause on the Johnson & Johnson vaccine won’t have a “significant impact” on its national vaccination effort as the Pfizer-BioNTech and Moderna vaccine supply remains steady.
The White House’s reassurance comes after the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) the same day called to halt administration of Johnson & Johnson vaccinations in the U.S. due to rare cases of blood clots.
“This announcement will not have a significant impact on our vaccination plan: Johnson & Johnson vaccine makes up less than 5 percent of the recorded shots in arms in the United States to date,” Jeff Zients, the White House COVID-19 response coordinator, said in a statement….
Panel Extends Pause on J&J Vaccine
“A federal advisory panel declined Wednesday to vote on how Johnson & Johnson’s Covid-19 vaccine should be used, saying it needs more time to gather information on the risk of the shot following reports of cases of rare but severe blood clots that developed in a few recipients,” the Wall Street Journal reports.
Politico: States fret pause in J&J vaccine could drive up hesitancy.